TY - JOUR T1 - A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. AU - Haroon,T S, AU - Hussain,I, AU - Aman,S, AU - Jahangir,M, AU - Kazmi,A H, AU - Sami,A R, AU - Nagi,A H, AU - Alvi,K H, AU - Iqbal,N, AU - Khan,K A, AU - Aziz,R, PY - 1996/7/1/pubmed PY - 1996/7/1/medline PY - 1996/7/1/entrez SP - 86 EP - 8 JF - The British journal of dermatology JO - Br J Dermatol VL - 135 IS - 1 N2 - We report a randomized, double-blind study, comparing the relative efficacy and tolerability of oral terbinafine, given for 1, 2 or 4 weeks, in tinea capitis. Of 161 evaluable patients, 53 were treated with terbinafine for 1 week, 51 for 2 weeks and 57 for 4 weeks. Isolated pathogens included Trichophyton violaceum (71.5%), T. tonsurans (14.9%), T. verrucosum (4.3%), Microsporum audouinii (4.3%), M. canis (2.5%), T. schoenleinii (1.9%) and T. mentagrophytes (0.6%). The final evaluation, at 12 weeks, showed cure rates of 73.6, 80.4 and 85.9%, in the respective groups. The adverse effects noted, were not drug related. In our opinion, terbinafine given for 1, 2 or 4 weeks, is equally effective for most cases of tinea capitis. SN - 0007-0963 UR - https://www.unboundmedicine.com/medline/citation/8776365/A_randomized_double_blind_comparative_study_of_terbinafine_for_1_2_and_4_weeks_in_tinea_capitis_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0007-0963&date=1996&volume=135&issue=1&spage=86 DB - PRIME DP - Unbound Medicine ER -